Rociletinib T2369
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Rociletinib is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
CAS nr:
1374640-70-6
Purity:
98%
Molecular Weight:
555,55
SMILES:
COc1c(Nc2ncc(c(Nc3cc(NC(=O)C=C)ccc3)n2)C(F)(F)F)ccc(c1)N1CCN(CC1)C(=O)C
Formula:
C27H28F3N7O3
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
EGFR,EGFR,EGFR
